| Preface |
|
VII | |
| Section A: Bases of Understanding the Spinal Cord |
|
1 | (50) |
|
Chapter 1 Neuroanatomical Considerations |
|
|
|
|
|
3 | (23) |
|
1.1 Gross Anatomy of the Human Spinal Cord |
|
|
3 | (5) |
|
|
|
8 | (1) |
|
1.3 Cross-Sectional Anatomy of the Spinal Cord |
|
|
8 | (6) |
|
1.4 Afferent Input to the Spinal Cord |
|
|
14 | (3) |
|
1.5 Somatosensory and Other Ascending Tracts |
|
|
17 | (4) |
|
1.5.1 Dorsal Column System |
|
|
17 | (3) |
|
1.5.2 Spinothalamic and Associated Tracts of the Anterolateral Quadrant |
|
|
20 | (1) |
|
1.6 Input to the Spinal Cord from Pathways Descending from the Brain |
|
|
21 | (5) |
|
1.6.1 Corticospinal Tract |
|
|
22 | (2) |
|
1.6.2 Other Descending Pathways from the Brain |
|
|
24 | (1) |
|
1.6.3 Spino-Bulbospinal and Other Spinal Cord-Brain Loops |
|
|
24 | (2) |
|
Chapter 2 Physiology of the Spinal Cord |
|
|
|
|
|
26 | (8) |
|
2.1 Electrophysiological Recordings from the Spinal Cord |
|
|
26 | (3) |
|
2.1.1 Single Unit Recordings |
|
|
26 | (1) |
|
2.1.2 Population Recordings |
|
|
26 | (3) |
|
2.2 Responses of Nociceptive Dorsal Horn Neurons to Peripheral Input |
|
|
29 | (3) |
|
2.3 Responses of Spinal Cord Neurons to Corticospinal Volleys |
|
|
32 | (2) |
|
Chapter 3 Pharmacology of the Spinal Cord |
|
|
|
|
|
34 | (6) |
|
Chapter 4 Overviews of Human (Evoked) Spinal Cord Potentials (SCPs): Recording Methods and Terminology |
|
|
|
|
|
40 | (13) |
|
4.1 Animal SCPs and Human SCPs |
|
|
40 | (4) |
|
4.2 Recording Methods of Human SCPs from the Posterior Epidural Space |
|
|
44 | (2) |
|
4.3 Six Different Kinds of Human SCPs Recorded from the Epidural Space |
|
|
46 | (7) |
|
4.3.1 Segmental SCPs (Segmentally Evoked SCPs) |
|
|
46 | (1) |
|
4.3.2 Conducting or Conducted SCPs |
|
|
46 | (2) |
|
4.3.3 Slow SCPs Produced by Antidromic Stimulation of the Spinal Cord (Descending SCP) |
|
|
48 | (1) |
|
4.3.4 Heterosegmental SCP, Heterosegmentally Evoked SCP |
|
|
48 | (1) |
|
4.3.5 Motor Evoked Human SCPs: TCM-Evoked SCPs |
|
|
49 | (1) |
|
4.3.6 Motor Evoked Human SCPs: TCE-Evoked SCPs |
|
|
49 | (1) |
|
4.3.7 Polarity of Recording Spinal Cord Potential |
|
|
49 | (2) |
| Section B: Somatosensory Evoked Spinal Cord Potentials (Segmental SCPs) |
|
51 | (52) |
|
|
|
|
SUMIHISA AIDA and KOKI SHIMOJI |
|
|
53 | (12) |
|
1.1 Waveform Characteristics |
|
|
53 | (1) |
|
1.2 Comparison with Skin Surface Recordings |
|
|
54 | (1) |
|
1.3 Comparison with Posterior Pharyngeal Recordings |
|
|
54 | (3) |
|
1.4 Origins of the Segmental SCP |
|
|
57 | (8) |
|
1.4.1 The Initially Positive Spike (Triphasic Spike) (PI) |
|
|
57 | (1) |
|
1.4.2 The Sharp (or Slow) Negative Wave (NI) |
|
|
57 | (4) |
|
1.4.3 The Slow Positive Wave (P Wave; P2 Wave) |
|
|
61 | (4) |
|
Chapter 2 Spinal Cord Potentials Evoked by Ascending Volleys |
|
|
|
YOICHI MARUYAMA and KOKI SHIMOJI |
|
|
65 | (6) |
|
2.1 Waveform Characteristics of SCPs Evoked by Ascending Volleys |
|
|
65 | (1) |
|
2.2 SCPs Evoked by Two Ascending Volleys from the Cauda Equina |
|
|
66 | (1) |
|
2.3 Conduction Velocities of Ascending Volleys Along the Cord |
|
|
67 | (4) |
|
Chapter 3 Spinal Cord Potentials Evoked by Descending Volleys |
|
|
|
HIROYUKI SHIMIZU and KOKI SHIMOJI |
|
|
71 | (11) |
|
3.1 Waveform Characteristics of SCPs Evoked by Descending Volleys to the Spinal Cord |
|
|
71 | (2) |
|
3.2 Effects of Graded Stimulation to Determine the Population of Spinal Tract Fibers that Produce "Descending SCPs" |
|
|
73 | (3) |
|
3.3 Effects of Double Shocks on "Descending SCPs" |
|
|
76 | (1) |
|
3.4 Origins of Descending N and P Waves in Human SCPs |
|
|
77 | (2) |
|
3.5 Spinal Tracts Producing N and P Waves |
|
|
79 | (3) |
|
Chapter 4 Heterosegmental SCPs (HSPs) |
|
|
|
MISAO TOMITA and KOKI SHIMOJI |
|
|
82 | (8) |
|
|
|
82 | (1) |
|
4.2 Fundamental Patterns of the HSP |
|
|
83 | (2) |
|
4.3 Central Nuclei of the HSP |
|
|
85 | (2) |
|
4.4 The Relationship Between WDR Neuron Activities and HSP |
|
|
87 | (3) |
|
Chapter 5 Clinical Pharmacology |
|
|
|
TATSUHIKO KANO and YOSHIKADO MIYAGAWA |
|
|
90 | (15) |
|
|
|
90 | (1) |
|
5.2 Effects of Intravenous Anesthetics |
|
|
91 | (7) |
|
|
|
91 | (2) |
|
5.2.2 Ketamine Hydrochloride |
|
|
93 | (1) |
|
5.2.3 Fentanyl Citrate and Droperidol |
|
|
94 | (1) |
|
5.2.4 Morphine Hydrochloride |
|
|
94 | (1) |
|
|
|
95 | (1) |
|
|
|
96 | (2) |
|
5.3 Effects of Inhalation Anesthetics |
|
|
98 | (1) |
|
5.4 Effects of Local Anesthetics |
|
|
98 | (7) |
|
5.4.1 Epidural Lidocaine on Segmental SCPs |
|
|
98 | (2) |
|
5.4.2 Epidural Lidocaine on Conducting SCPs |
|
|
100 | (1) |
|
5.4.3 Intrathecal Lidocaine on Conducting SCPs |
|
|
101 | (1) |
|
|
|
102 | (1) |
| Section C: Motor Evoked SCPs |
|
103 | (32) |
|
Chapter 1 Transcranial Magnetically Evoked SCPs (TCM-Evoked SCPs) |
|
|
|
TOSHIYUKI TOBITA and KOKI SHIMOJI |
|
|
105 | (7) |
|
|
|
105 | (1) |
|
1.2 Basic Patterns of TCM-Evoked SCPs |
|
|
106 | (1) |
|
1.3 Effects of Intravenous Anesthetics |
|
|
107 | (3) |
|
1.4 Effects of Inhalation Anesthetics |
|
|
110 | (2) |
|
Chapter 2 Transcranial Electrically Evoked SCPs (TCE-Evoked SCPs) |
|
|
112 | (23) |
|
|
|
|
CHIKASHI FUKAYA and YOICHI KATAYAMA |
|
|
112 | (6) |
|
|
|
112 | (1) |
|
|
|
112 | (1) |
|
|
|
112 | (1) |
|
|
|
113 | (4) |
|
|
|
117 | (1) |
|
2.2 TCE-Evoked SCPs in Animals and Human |
|
|
|
YOICHI KATAYAMA and TAKAMITSU YAMAMOTO |
|
|
118 | (6) |
|
|
|
118 | (1) |
|
2.2.2 Experimental Studies |
|
|
119 | (2) |
|
2.2.3 Comparison Between Direct- and TCE-evoked SCPs |
|
|
121 | (3) |
|
2.3 TCE-Evoked Potentials from Muscle and TCE-Evoked SCPs |
|
|
|
TAKAMITSU YAMAMOTO and YOICHI KATAYAMA |
|
|
124 | (5) |
|
|
|
124 | (1) |
|
|
|
124 | (1) |
|
|
|
125 | (3) |
|
|
|
128 | (1) |
|
2.4 Effects of Intravenous and Inhalational Anesthetics |
|
|
|
S. DENDA and KOKI SHIMOJI |
|
|
129 | (8) |
|
|
|
129 | (1) |
|
2.4.2 Methods for Recording TCE-Evoked SCPs |
|
|
130 | (2) |
|
2.4.3 The Effects of Inhalation Anesthetics |
|
|
132 | (3) |
| Section D: Case Studies (Clinical Applications) |
|
135 | (45) |
|
Chapter 1 Monitoring by SCPs During Surgical Operations |
|
|
137 | (37) |
|
1.1 Spine Surgery: Scoliosis Surgery |
|
|
|
HITOSHI FUJIOKA and KOKI SHIMOJI |
|
|
137 | (3) |
|
|
|
140 | (10) |
|
1.2.1 Dorsal Root Entry Zone Lesion (DREZL) |
|
|
|
TOMOHIRO YAMAKURA and KOKI SHIMOJI |
|
|
40 | (103) |
|
|
|
|
CHIKASHI FUKAYA and YOICHI KATAYAMA |
|
|
143 | (7) |
|
1.3 Spinal Cord Hypothermia During Aortic Surgery |
|
|
|
TATSUHIKO KANO and SEIJI WATANABE |
|
|
150 | (3) |
|
|
|
151 | (2) |
|
1.4 Spinal Cord Ischemia During Aortic Surgery |
|
|
153 | (7) |
|
1.4.1 Somatosensory Evoked SCPs |
|
|
|
TATSUHIKO KANO and HIDEKI HARADA |
|
|
153 | (3) |
|
1.4.2 TCE-Evoked Electromyograms During Thoracoabdominal Aortic Surgery |
|
|
|
SATORU FUKUDA and HAI-LONG DONG |
|
|
156 | (4) |
|
1.5 Cardiovascular Surgery |
|
|
160 | (14) |
|
1.5.1 Somatosensory Evoked SCPs |
|
|
|
TOSHIKAZU TAKADA and KOKI SHIMOJI |
|
|
160 | (5) |
|
1.5.2 Motor Evoked Potential |
|
|
|
SATORU FUKUDA and HAI-LONG DONG |
|
|
165 | |
|
Chapter 2 Diagnosis by Spinal Cord Potentials of Spinal Diseases |
|
|
|
HIROYUKI SHIMIZU and KOKI SHIMOJI |
|
|
174 | (6) |
|
2.1 Spinal Cord Potentials in Patients with ALS |
|
|
175 | (1) |
|
2.2 Spinal Cord Potentials in Patients with Tabes Dorsalis |
|
|
176 | (1) |
|
2.3 Spinal Cord Potentials in Patients with Spinal Tumors |
|
|
177 | (3) |
| References |
|
180 | (27) |
| Index |
|
207 | |